Alterations in the prothrombin coagulation pathway due to preeclampsia
Lox, C.D.; Maciulla, G.J.; Corrigan, J.J.
Obstetrics and Gynecology 54(5): 635-638
1979
ISSN/ISBN: 0029-7844 PMID: 503393 Document Number: 151679
Circulating plasma levels of human prothrombin antigen and activity were determined in normal pregnancy and in pregnancies complicated by hypertension, eclampsia, or preeclampsia. The ratio of prothrombin antigen to activity (Ag/Act) was within normal limits for all hypertensive patients. However, every untreated preeclamptic patient, as well as 2 eclamptic patients, had abnormal prothrombin antigen to activity ratios.
Document emailed within 1 workday
Related Documents
Doellgast, G.J.; Triscott, M.X.; Buss, D.H.; West, J. 1988: Extrinsic-pathway enzyme-linked coagulation assay (EP-ELCA). a clot-based alternative to prothrombin time for measurement of extrinsic pathway factors in plasma Clinical Chemistry 34(2): 294-299Abdelghaffar, H.; Vazifeh, D.; Labro, M.T. 1997: Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway: L-cladinose is involved both in alterations of neutrophil functions and modulation of this transductional pathway Journal of Immunology 159(8): 3995-4005
Takeda, Y. 1970: Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system Journal of Laboratory and Clinical Medicine 75(3): 355-381
Bardeguez, A.D.; McNerney, R.; Frieri, M.; Verma, U.L.; Tejani, N. 1991: Cellular immunity in preeclampsia: alterations in T-lymphocyte subpopulations during early pregnancy Obstetrics and Gynecology 77(6): 859-862
Sharashenidze, A.; Panchulidze, L.; Sanikidze, T. 2017: Alterations in Placenta Redox-Status during Experimental Model of Hypoxia-Induced Preeclampsia Georgian Medical News 2017(268-269): 86-90
Ono, M.; Ohta, H.; Ohhira, M.; Sekiya, C.; Namiki, M. 1990: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma American Journal of Gastroenterology 85(9): 1149-1154
Djelmis, J.; Buković, D.; Ivanisević, M.; Kovacević, V.; Pfeifer, D. 1998: Effects of preeclampsia and eclampsia on cord blood coagulation tests Collegium Antropologicum 22(1): 113-117
Owen, C.A.; Mann, K.G.; McDuffie, F.C. 1979: The turnover in normal dogs of prothrombin and its fragments; effect of induced intravascular coagulation Thrombosis and Haemostasis 42(2): 548-555
Dobrynina, L.A.; Kalashnikova, L.A.; Patrusheva, N.L.; Kovalenko, T.F.; Patrushev, L.I. 2012: Polymorphism of 5,10-methylenetetrahydropholate reductase, prothrombin, and coagulation factor V genes in young patients with ischemic stroke Klinicheskaia Meditsina 90(3): 37-40
Leroy-Matheron, C.; Gouault-Heilmann, M. 1994: Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements Thrombosis Research 74(4): 399-407
Larraín, C. 1994: Congenital blood coagulation factor X deficiency. Successful result of the use prothrombin concentrated complex in the control of ++cesarean section hemorrhage in 2 pregnancies Revista Medica de Chile 122(10): 1178-1183
Hoffmann, J.J. 1985: Monitoring the intrinsic pathway of coagulation during heparin therapy Thrombosis and Haemostasis 53(1): 161
Cui, J.; Zhou, X.; Liu, Y.; Tang, Z.; Romeih, M. 2003: Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma Chinese Medical Journal 116(12): 1885-1892
Barbe, D.; Bauduer, F.; Tanguy, A. 1991: Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100 Annales de Biologie Clinique 49(10): 507-513
Nakahara, Y.; Takemoto, S.; Kamikubo, Y.; Miyamoto, S. 1997: Vascular smooth muscle cell and extrinsic coagulation pathway Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 104: 205-215
Vinazzer, H.; Bergmann, H. 1975: The influence of hydroxyethyl starch on postoperative alterations of blood coagulation Der Anaesthesist 24(12): 517-520
Porta, M. 1980: Alterations of blood coagulation and endothelial function in diabetic microangiopathy Minerva Medica 71(2): 119-130
Akhavan, S.; Lavoretano, S.; Chantarangkul, V.; Mannucci, P.M. 2002: Plasma prothrombin levels are not associated with mutations in the promoter region of the prothrombin gene Thrombosis and Haemostasis 88(5): 877-878
Rao, L.V.; Hoang, A.D.; Rapaport, S.I. 1995: Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin Thrombosis and Haemostasis 73(4): 668-674
Jaekel H.-P.; Trabandt A.; Schmid D.; Grobe N.; Müller E.-W.; Ziutelis V.; Kaskel-Paul S.; Höh H.; Bauer B.; Sudik R.; Baldauf A.; Werle E. 2004: Autoantibodies to Prothrombin and Phosphatidylserine/Prothrombin-Complexes: Do they contribute to the Serodiagnosis of Primary and Secondary Anti-Phospholipid Syndrome? Clinical Laboratory 50(5-6): 295-304